Development of a COVID-19 vaccine effectiveness and safety assessment system in Japan: The VENUS study.

ABSTRACT:

Background

There are currently no COVID-19 vaccine assessment systems in Japan that allow for the active surveillance of both vaccinated and unvaccinated persons. Herein, we describe the development of Japan's first COVID-19 vaccine effectiveness and safety assessment system with active surveillance capabilities.

Methods

The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) Study was developed as a multi-source database that links four data types at the individual resident level: Basic Resident Register (base population information), Vaccination Record System (vaccination-related information), Health Center Real-time Information-sharing System on COVID-19 (HER-SYS; information on COVID-19 occurrence), and health care claims data (information on diagnoses, hospi

SUBMITTER: Fukuda H 

PROVIDER: S-EPMC10050280 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature